Sales & Marketing Director
Chief Executive Officer – ProBiotix
OptiBiotix is a life sciences company operating in one of the most progressive areas of biotechnological research – the modulation of the human microbiome. The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes.
OptiBiotix was founded in 2012 by Stephen O’Hara, founder and CEO, a visionary life science entrepreneur with a track record of building successful organisations (Acolyte Biomedica and Intelligent Biotech). OptiBiotix successfully listed on AIM in 2014 since when it has performed strongly.
When the Board crystalized its ambitious growth strategy in 2017, they engaged Sally Hope to support the build out of the Board, hiring a Sales & Marketing Director, Commercial Director and Non-Executive Chair as part of the succession planning for the parent and subsidiary spin-outs. This resulted in the appointment of Christina Wood, Per Rehne and Neil Davidson during 2017 and 2018. In October 2018 the company launched a 100% owned subsidiary ProBiotix Health Limited, Sally was engaged to undertake an extensive global CEO search for the new business resulting in the appointment of Steve Prescott in May 2019.
“I first engaged Sally and the team at PIR in 2017 for two Senior Commercial Director positions, and was impressed by their professionalism and ability to deliver a good range of suitable candidates. Since then PIR has become a trusted partner to OptiBiotix Health plc, they are great to work with; collaborative, transparent and through their Search process we have been able to successfully appoint a Chairman for our plc Board and a CEO based in the US for our newly created subsidiary ProBiotix Health. I look forward to continuing our successful partnership with PIR”
Stephen O’Hara, Chief Executive, OptiBiotix Health PLC